Free U.S. shipping $175+

LL-37 — Novaryn Research
Hover to zoom
Immune & InflammatorySynthetic research compound

LL-37

$59.99
5 mg

LL-37 is the active 37-residue peptide released from human cathelicidin (hCAP18), and the only cathelicidin-derived antimicrobial peptide identified in humans.

It is amphipathic and cationic, allowing it to interact with negatively charged microbial membranes, and it is studied both as an antimicrobial agent in vitro and as a signaling molecule involved in innate immune responses.

Research areas
Antimicrobial peptide researchInnate immune signalingMembrane biophysicsHost-defense models
Form: Lyophilized (freeze-dried)
Compound class
Synthetic research compound
Research category
Immune & Inflammatory
SKU
NVR-LL-37-5MG
Appearance
Lyophilized powder
Storage
Store lyophilized at −20 °C. Protect from light and moisture.
Research use only
Strength
5 mg$59.99$12.00/mg
1
$59.99per 5 mg$12.00/mg

For research use only — not for human or animal consumption.

Supplied solely for legitimate laboratory and research purposes. Not for medical or veterinary use, diagnosis, treatment, or prevention of disease.

Research Grade
Batch Documentation
Research Use Only
U.S.-Based Fulfillment
What you should know

More detail on LL-37.

Analytical values reflect per-lot documentation and appear once a batch is released.

Compound
LL-37 has a dual research profile. As an antimicrobial, it disrupts bacterial membranes in a concentration-dependent manner, and it is a standard reference peptide in minimum-inhibitory-concentration and membrane-permeabilization assays. As an immune modulator, published work describes interactions with host cell receptors, influence on chemotaxis, and binding to nucleic acids that alters innate sensing. Laboratory applications span microbiology, biophysics, and immunology. Activity is strongly salt- and serum-dependent, so assay conditions must be reported carefully.
Peptide class
Synthetic research compound
Mechanism (research context)
Extended mechanistic characterization for this compound is available in the published literature. Consult peer-reviewed references for detailed pathway analysis.
Why it is studied
LL-37 is studied within its research category (Immune & Inflammatory) as a defined-sequence reference compound for laboratory investigation.
Current areas of research
Antimicrobial peptide researchInnate immune signalingMembrane biophysicsHost-defense models

Topics reflect published preclinical and in vitro research. Reference only — not a claim of clinical outcomes.

Scientific background

LL-37 is supplied for in vitro laboratory research. Batch-specific analytical documentation is provided when available for the released lot.

Related

Related research materials

View all →
LL-37
5 mg · $59.99
Notify me when available